secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0000950170-25-058334
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Healthcare Q1 revenue $18.3B, EPS $6.45, adjusted EBITDA $3.73B, reaffirms guidance
--------------------------------------------------------------------------------

- Revenue $18.321B (+5.7% YoY); net income $1.610B, diluted EPS $6.45 (vs $5.93 prior year).
- Adjusted EBITDA $3.733B (+11.3% YoY); same facility admissions +2.6%, ER visits +4.0%.
- Cash from ops $1.651B (down from $2.469B); repurchased 7.762M shares for $2.506B.
- Declared quarterly dividend $0.72/share, payable June 30 to holders of record June 16.
- Reaffirmed full-year 2025 guidance ranges including Adjusted EBITDA and EPS.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000095017025058334/0000950170-25-058334-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000095017025058334/hca-20250425.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-058334

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer